Patents on Inventions Involving AI in the Life Sciences and Healthcare

Anna Katharina Heide ()
Additional contact information
Anna Katharina Heide: German and European Patent Attorney, Ruhr-IP Patent Attorneys

A chapter in The Future Circle of Healthcare, 2022, pp 147-178 from Springer

Abstract: Abstract In recent years, the relevance of artificial intelligence (AI) and its potential applications in various technical areas of the life sciences and healthcare have increased. The accumulation of big data, the development of algorithms, and improvements in computer processing capacity have made possible the integration of AI in the life sciences and healthcare. Some examples of AI applications in these fields are drug and molecular design, the prediction of disease risk, diagnosis of diseases, detection of cancerous cells and tumors, genomics, the monitoring of therapeutic progress, the adjustment of therapeutic treatment, and improvements in manufacturing processes. Such applications change the mode of work in hospitals and for doctors and give rise to interdisciplinary products for which a company seeks a monopoly under patent law. A patented technical monopoly may facilitate a company a dominant market position and a return on investment. However, a patent monopoly is subject to legal regulations that define the preconditions for a patent grant as well as exclusion criteria. These may vary in the particular country for which a patent is sought. This chapter is based on the European Patent Convention (EPC) and the case law of the Boards of Appeal of the European Patent Office (EPO). The examples of granted or refused patents presented here may be assessed differently by other jurisdictions [e.g., the United States Patent and Trademark Office (USPTO), Japan Patent Office (JPO), China National Intellectual Property Administration (CNIPA)].

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:fuobcp:978-3-030-99838-7_9

Ordering information: This item can be ordered from
http://www.springer.com/9783030998387

DOI: 10.1007/978-3-030-99838-7_9

Access Statistics for this chapter

More chapters in Future of Business and Finance from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().